Manomay Clinical Research Institute Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Months 10 Days
About Manomay Clinical Research Institute
Manomay Clinical Research Institute Private Limited (MCRIPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 June 2024 ( seven months 10 days old ). Its registered office is in Nashik, Maharashtra, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prarthana Nagarkar, Viren Nagarkar, Shrikant Suryavanshi, and One other member serve as directors at the Company.
Company Details
-
Location
Nashik, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U86100MH2024PTC427810
-
Company No.
427810
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Jun 2024
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Who are the key members and board of directors at Manomay Clinical Research Institute?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prarthana Nagarkar
|
Director | 26-Jun-2024 | Current |
|
Viren Nagarkar
|
Director | 26-Jun-2024 | Current |
|
Shrikant Suryavanshi
|
Director | 26-Jun-2024 | Current |
|
Aastha Nagarkar
|
Director | 26-Jun-2024 | Current |
Financial Performance of Manomay Clinical Research Institute.
Enhance accessibility to Manomay Clinical Research Institute's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manomay Clinical Research Institute?
Unlock access to Manomay Clinical Research Institute's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Raj Nagarkar Medical Foundation Private LimitedPrarthana Nagarkar is a mutual person
-
Kims Manavata Hospitals Private Limited
Prarthana Nagarkar and Viren Nagarkar are mutual person
-
Vds Home Healthcare Solutions Private Limited
Viren Nagarkar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Manomay Clinical Research Institute?
Unlock and access historical data on people associated with Manomay Clinical Research Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manomay Clinical Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manomay Clinical Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.